1Onda H, Kasuya H, Takakura K et cd. Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemor- rhage[J].J Cereb Blood Flow Metab, 1999; 19:1279-1288.
2Baekkevold E S, Roussigaae M, Yamanaka T et al. Molecular characteriza- tion of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules [ J ]. Am J Pathol, 2003 ; 163 : 69-79.
3Scbmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like ey- tokine that signals via the IL-1 receptor celated protein ST2 and induces T heloer tvoe 2-associated cytokines [J]. Immunity, 2005 ; 23 ( 5 ) : 479-490.
4Smithgall M D,Comeau M R,Yoon B R et al.IL-33 amplifies both Thl- and Th2-type responses through its activity on human basophiles, allergen reactive Th2 ceils, iNKT and NK cells [ J ]. Int Immunol, 2008 ; 20 ( 8 ) : 1019-1030.
5Chackerian A A, Oldham E R, Murphy E E et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex[ J]. Immunol, 2007; 179 : 2551-2555..
6Lin J C,Gutierrez Ramos D,Levinson A et al.T1/ST2 Preferentially ex- pressed on murine Th2 cells, independent of interleukin-4, interleukin-5 and interleukin-10, and important for Th2 effector function[ J ]. Proc Natl Aead Sci, 1994; 95 : 6930-6935.
7Hayakawa H, Hayakawa M, Kume A et al. Soluble ST2 blocks interleukin- 33 signaling in allergic airway inflammation[ J]. J Biol Chem, 2007 ; 282 : 26369-26380.
8Louten J, Rankin A L, H Y et al. Endogenous IL-33 enhances Th2 cy- tokine production and T-cell responses during allergic airway inflammation [JJ. Int Immunol,2011 ;23(5) :307-315.
9Tomomilsu M, Makoto S, Hitomi Yet al. High levels of soluble ST2 and low levels of IL-33 in sera of patients with HIV infection[J]. J of Inves- tigative Dermatoloev, 2011 ; 131 : 794-796..
10Becerra A, Warke R V, Bosch Net al. Elevated levels of soluble ST2 protein in dengue virus infected patients[J]. Cytokine, 2008; 41 (2) : 114-120.
同被引文献28
1胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
2BLYSTAD H, A NESTAD G, VESTRHEIM DF, et al. Increased incidence of mycoplasma pneumoniae infection in Norway 2011 [J]. Eurosurveillance (Online), 2012, 17(5): 12-14.
3CAO B, REN LL, ZHAO F, et al. Viral and myeoplasma pneu- monia community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China[J]. Eur J Clin Microbiol Infect Dis, 2010, 29(11): 1443-1448.
4BETFELLI E, KORN T, OUKKA M, et al. Induction and effeetor functions of TH-17 cells[J]. Nature, 2008, 453(7198): 1051-1057.
5MILLER ASHLEY M. Role of IL-33 in inflammation and dis- ease[J]. Journal of Inflammation, 2011, 8: 22.
6IVANOV S, BOZINOVSKI S, BOSSIOS A, et al. Functional relevance of the IL-23 IL-17 axis in lungs in vivo [J]. Am J Respir Cell Mol Biol, 2007, 36(4): 442-451.
7HUMPHREYS NE, XU D, HEPWORTH MR, et al. Grencis RK: IL-33, a potent inducer of adaptive immunity to intestinal nematodes[J]. J Immunol 2008, 180(4): 2443-2449.
8CARRIERE V, ROUSSEL L, ORTEGA N, et al. IL-33, the IL-1 like cytokine ligand for ST2 receptor, is a chromatin- as- sociated nuclearfactor in vivo [J]. Proc Natl Acad Sci USA, 2007_ ll)zL(1]: 282-287_.
9Tomomitsu M,Makoto S,Hitomi Y,et al.High levels of soluble ST2and low levels of IL-33 in sera of patients with HIV infection[J].J of Investigative Dermatology,2011,131:794-796.
10Volarevic V,Mitrovic M,Milovanovic M.Protective role of IL-33/ST2 axis in Con A-induced hepatitis[J].J Hepatol,2012,56(1):26-33.
